HealthcareJul 16, 2026

Lupin

Company Profile Analysis

Book Demo Subscribe Now

Year Founded & Workforce

1967-12-31

15,000 Employees

Industry

Healthcare

Services

Lupin Overview

Company Headquarter: Mumbai, India

Founded: 1968

Workforce: 15,000+

Company Working:

Lupin is a global pharmaceutical company that deals in a wide range of products such as branded and generic formulations, biotechnology products, APIs, and specialty drugs. The company is a prominent player in the therapeutic segment such as gynecology, cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal (GI), anti-infective (AI), and non-steroidal anti-inflammatory drugs (NSAIDS). Also, it has a global leader in the fields of the anti-TB and Cephalosporin segment. Lupin has a presence in more than 100 countries. It has 18 manufacturing facilities, located in many parts of India, Japan, the US, Mexico, and Brazil. All these facilities are benchmarked to international standards to meet stringent quality standards. Also, these facilities are approved by international agencies such as the US FDA, UK MHRA, Japan’s MHLW, TGA Australia, WHO, and the MCC South Africa.

Strategy

Lupin improves its clinical outcomes through new, more accurate, and fast, innovative methods. It focusses on optimizing the cost of capital based on market conditions and makes investments in untapped markets. The company wants to build an efficient capital structure and strong shareholder returns by enhancing its disease management programs in active pharmaceutical ingredients and others.

Company Snapshot

$1,962.51M

Revenue

15,000

Employees

1967-12-31

Founded

SWOT Analysis

Strengths

Industrial diversity and unique products
High customer loyalty
Strong management and high expertise
Largest generics player in the US and Japanese markets
Presence in more than 70 countries

Weaknesses

Need more investments in new technologies
Material weakness

Opportunities

Expansions of products and services
Acquisitions to strengthen industrial technologies and the therapeutics field

Threats

Changes in regulations of healthcare and related industries
The demand for highly profitable products is seasonal and any unlikely event during the peak season may impact the profitability of the company in short to medium term

Key Developments

Date	Approach	Development
July 2018	MHRA Approval	Lupin received the UK Medicine’s and Healthcare Products Regulatory Agency (MHRA) approval for its Goa facility.
October 2017	Product Launch	Lupin got the USFDA approval to market the generic hypertension drug, nadolol tablets in the US market. Nadolol is used alone or in combination with other medications to treat high blood pressure. In the US, nadolol tablets had annual sales of around USD 109.8 million in 2017.
August 2016	Acquisition	Lupin acquired the branded product portfolio from Shionogi in Japan. With this, Lupin aims to grow globally as a drug discovery-based pharmaceutical company.
March 2016	Acquisition	Lupin completed its acquisition of the US-based pharmaceutical companies, GAVIS LLC and Novel Laboratories, Inc.
October 2015	Strategic Agreement	Lupin and Boehringer Ingelheim announced a strategic co-marketing agreement in India.
September 2015	Product Launch	Lupin launched Duloxetine 40 mg delayed-release (DR) capsule, which was the first and only generic duloxetine formulation to become available in the 40 mg dosage strength.
July 2015	Acquisition	Lupin acquired a specialty product portfolio of Temmler Pharma GmbH & Co. KG, Germany.
March 2015	Acquisition	Lupin completed the acquisition of the South African generic major, Pharma Dynamics.

Product Offering

Lupin
- Antihypertensive Combination
- Antihypertensive
- Chronic Heart Failure
- Mindvision
- Pain Relievers (NSAIDs)

Financial Performance

A plan for every need

Forecast+

Get unlimited access to forecasts, charts, and company data across every research report on Wantstats.

USD200/mo

About the Author

Wantstats Research Team

Wantstats' research desk profiles Lupin as part of our ongoing coverage of the Healthcare sector, drawing on public company data, filings, and market intelligence.

Powering the world's best teams.
From next-gen startups to established enterprises.

See our work in action

Start your data driven journey with us!

Book a Demo Now

What our clients say

Trusted by forward-thinking businesses
for data-driven intelligence

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Noah Malgeri

Co-Founder, Mojave Rail Fabrication Limited

This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.

Michael Robert

Manager, JavolVision

Thanks, I am so happy that we worked together. Maybe we still can work together in the future.

Joseph Aguayo

Sales Operations & Pricing Manager, Intel

Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.

Bong Lau

Sales Leader, Bamberg

We bought your "2025 report" in 2020. Everything is fine and very good.

Peter Groot Koerkamp

Account and Business Manager, EFS-Holland BV

Thanks for sending the report it gives us a good global view of the Betaïne market.

Younghwan Choi

Senior Retail Manager, LG Chem

We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.

Mark Irwin

Management Consultant, Level 21

I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.

Rob Kooiker

Group Product Manager HVAC & Fire Protection GMA, Rockwool

I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!

Jason Lee

R&D Director, Seojin

Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.

Akif Moroglu

Strategy & Business Development Director, Dogan Holding

We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.

Lupin

Company Headquarter: Mumbai, India Founded: 1968 Workforce: 15,000+ Company Working: Lupin is a global pharmaceutical company that deals in a wide range of products such as branded and generic formulations, biotechnology products, APIs, and specialty drugs. The company is a prominent player in the therapeutic segment such as gynecology, cardiovascular, diabetology, asthma, pediatric, central nervous system, gastrointestinal (GI), anti-infective (AI), and non-steroidal anti-inflammatory drugs (NSAIDS). Also, it has a global leader in the fields of the anti-TB and Cephalosporin segment. Lupin has a presence in more than 100 countries. It has 18 manufacturing facilities, located in many parts of India, Japan, the US, Mexico, and Brazil. All these facilities are benchmarked to international standards to meet stringent quality standards. Also, these facilities are approved by international agencies such as the US FDA, UK MHRA, Japan’s MHLW, TGA Australia, WHO, and the MCC South Africa.

Starting from

$4,950